Skin cancer screening specialist, The MOLE Clinic, finds a partner to support its growth with the help of Smith & Williamson
Smith & Williamson advised skin cancer screening specialist The Mole Clinic on its sale to private equity backed Sk:n
The MOLE Clinic is a leading independent provider of skin cancer screening, diagnosis and treatment services to private patients and to the NHS. It screens over 30,000 patients annually using advanced diagnostic techniques from five London clinics, including on Harley Street, Oxford Circus and Moorgate, as well as via its award-winning tele-dermatology offering to GPs nationally.
Demand for The MOLE Clinic’s services has been growing and the shareholders were looking for a strategic partner to help support their expansion. Smith & Williamson worked with the shareholders of The MOLE Clinic to deliver a successful sale to a strategic partner that is able to expand the clinic network and help support the business through its next phase of growth.
Sk:n is the largest network of specialist skin care clinics in the UK and is backed by Trispan, a specialist private equity firm. This acquisition further strengthens Sk:n’s skin cancer screening offering and adds to its growing range of skin care services. As part of integrating the business into the Group, they plan to roll out The MOLE Clinic’s offering across the Sk:n clinic network nationally.
Brian Livingston, Head of M&A for Smith & Williamson, led the transaction supported by Stuart Goodman and Joseph Sherry.
Iain Mack, Founder and Managing Director of The MOLE Clinic, said “I found the advice and hands on support provided by the Smith & Williamson team to be invaluable and a significant factor in achieving a successful transaction. Their understanding of the medical and healthcare sector as well as a focus on owner managed businesses proved vital in not just solving problems but anticipating and addressing them before they arose. I cannot recommend their team highly enough.”
Brian Livingston, Head of M&A for Smith & Williamson, said “This transaction illustrates the demand for specialist operators of medical and healthcare services even in this market. The roll out model is becoming increasingly attractive to established trade players and private equity alike and we expect to see many more deals of this nature. The management team of Mole Clinic had done an excellent job of establishing and growing a quality business and we are very pleased to have worked with them on this successful sale, which reinforces our strong track record of completed transactions in the healthcare sector”.
For further information please contact:
By necessity, this briefing can only provide a short overview and it is essential to seek professional advice before applying the contents of this article. No responsibility can be taken for any loss arising from action taken or refrained from on the basis of this publication. Details correct at time of writing.
Note to editors
Smith & Williamson is an independently owned professional and financial services group with over 1,700 people. The group is a leading provider of investment management, financial advisory and accountancy services to private clients, professional practices and mid-to-large corporates. The group has twelve offices; these are in London, Belfast, Birmingham, Bristol, Cheltenham, Dublin (City and Sandyford), Glasgow, Guildford, Jersey, Salisbury and Southampton.
Smith & Williamson Corporate Finance Limited
Authorised and regulated by the Financial Conduct Authority. A member of Oaklins International Inc. For legal notices, please refer www.oaklins.com/legal.